343 related articles for article (PubMed ID: 15592805)
1. Regulatory polymorphisms underlying complex disease traits.
Knight JC
J Mol Med (Berl); 2005 Feb; 83(2):97-109. PubMed ID: 15592805
[TBL] [Abstract][Full Text] [Related]
2. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease.
Ueda H; Howson JM; Esposito L; Heward J; Snook H; Chamberlain G; Rainbow DB; Hunter KM; Smith AN; Di Genova G; Herr MH; Dahlman I; Payne F; Smyth D; Lowe C; Twells RC; Howlett S; Healy B; Nutland S; Rance HE; Everett V; Smink LJ; Lam AC; Cordell HJ; Walker NM; Bordin C; Hulme J; Motzo C; Cucca F; Hess JF; Metzker ML; Rogers J; Gregory S; Allahabadia A; Nithiyananthan R; Tuomilehto-Wolf E; Tuomilehto J; Bingley P; Gillespie KM; Undlien DE; Rønningen KS; Guja C; Ionescu-Tîrgovişte C; Savage DA; Maxwell AP; Carson DJ; Patterson CC; Franklyn JA; Clayton DG; Peterson LB; Wicker LS; Todd JA; Gough SC
Nature; 2003 May; 423(6939):506-11. PubMed ID: 12724780
[TBL] [Abstract][Full Text] [Related]
3. Combinatorial effects of multiple enhancer variants in linkage disequilibrium dictate levels of gene expression to confer susceptibility to common traits.
Corradin O; Saiakhova A; Akhtar-Zaidi B; Myeroff L; Willis J; Cowper-Sal lari R; Lupien M; Markowitz S; Scacheri PC
Genome Res; 2014 Jan; 24(1):1-13. PubMed ID: 24196873
[TBL] [Abstract][Full Text] [Related]
4. CTLA4 gene variants in autoimmunity and cancer: a comparative review.
Ghaderi A
Iran J Immunol; 2011 Sep; 8(3):127-49. PubMed ID: 21931200
[TBL] [Abstract][Full Text] [Related]
5. DNA sequence polymorphisms within the bovine guanine nucleotide-binding protein Gs subunit alpha (Gsα)-encoding (GNAS) genomic imprinting domain are associated with performance traits.
Sikora KM; Magee DA; Berkowicz EW; Berry DP; Howard DJ; Mullen MP; Evans RD; Machugh DE; Spillane C
BMC Genet; 2011 Jan; 12():4. PubMed ID: 21214909
[TBL] [Abstract][Full Text] [Related]
6. Ionizing radiation and genetic risks. VI. Chronic multifactorial diseases: a review of epidemiological and genetical aspects of coronary heart disease, essential hypertension and diabetes mellitus.
Sankaranarayanan K; Chakraborty R; Boerwinkle EA
Mutat Res; 1999 Jan; 436(1):21-57. PubMed ID: 9878681
[TBL] [Abstract][Full Text] [Related]
7. Type 1 Diabetes and Autoimmune Thyroid Disease-The Genetic Link.
Frommer L; Kahaly GJ
Front Endocrinol (Lausanne); 2021; 12():618213. PubMed ID: 33776915
[TBL] [Abstract][Full Text] [Related]
8. Functional implications of genetic variation in non-coding DNA for disease susceptibility and gene regulation.
Knight JC
Clin Sci (Lond); 2003 May; 104(5):493-501. PubMed ID: 12513691
[TBL] [Abstract][Full Text] [Related]
9. The Genotype and Phenotype (GaP) registry: a living biobank for the analysis of quantitative traits.
Gregersen PK; Klein G; Keogh M; Kern M; DeFranco M; Simpfendorfer KR; Kim SJ; Diamond B
Immunol Res; 2015 Dec; 63(1-3):107-12. PubMed ID: 26467974
[TBL] [Abstract][Full Text] [Related]
10. Technical note: linkage disequilibrium and disease-associated CTLA4 gene polymorphisms.
Holopainen PM; Partanen JA
J Immunol; 2001 Sep; 167(5):2457-8. PubMed ID: 11509583
[TBL] [Abstract][Full Text] [Related]
11. TNF, TNF receptor type 1, and allograft inflammatory factor-1 gene polymorphisms in Japanese patients with type 1 diabetes.
Nishimura M; Obayashi H; Mizuta I; Hara H; Adachi T; Ohta M; Tegoshi H; Fukui M; Hasegawa G; Shigeta H; Kitagawa Y; Nakano K; Kaji R; Nakamura N
Hum Immunol; 2003 Feb; 64(2):302-9. PubMed ID: 12559634
[TBL] [Abstract][Full Text] [Related]
12. CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases.
Blomhoff A; Kemp EH; Gawkrodger DJ; Weetman AP; Husebye ES; Akselsen HE; Lie BA; Undlien DE
Pigment Cell Res; 2005 Feb; 18(1):55-8. PubMed ID: 15649153
[TBL] [Abstract][Full Text] [Related]
13. Is there a future for TNF promoter polymorphisms?
Bayley JP; Ottenhoff TH; Verweij CL
Genes Immun; 2004 Aug; 5(5):315-29. PubMed ID: 14973548
[TBL] [Abstract][Full Text] [Related]
14. Functional evaluation of the type 1 diabetes (T1D) susceptibility candidate genes.
Park Y
Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S110-5. PubMed ID: 17448564
[TBL] [Abstract][Full Text] [Related]
15. Topological analysis of metabolic networks integrating co-segregating transcriptomes and metabolomes in type 2 diabetic rat congenic series.
Dumas ME; Domange C; Calderari S; Martínez AR; Ayala R; Wilder SP; Suárez-Zamorano N; Collins SC; Wallis RH; Gu Q; Wang Y; Hue C; Otto GW; Argoud K; Navratil V; Mitchell SC; Lindon JC; Holmes E; Cazier JB; Nicholson JK; Gauguier D
Genome Med; 2016 Sep; 8(1):101. PubMed ID: 27716393
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in miRNA genes and their involvement in autoimmune diseases susceptibility.
Latini A; Ciccacci C; Novelli G; Borgiani P
Immunol Res; 2017 Aug; 65(4):811-827. PubMed ID: 28741258
[TBL] [Abstract][Full Text] [Related]
17. Fine mapping genetic determinants of the highly variably expressed MHC gene ZFP57.
Plant K; Fairfax BP; Makino S; Vandiedonck C; Radhakrishnan J; Knight JC
Eur J Hum Genet; 2014 Apr; 22(4):568-71. PubMed ID: 24193346
[TBL] [Abstract][Full Text] [Related]
18. Human-genome single nucleotide polymorphisms affecting transcription factor binding and their role in pathogenesis.
Antontseva EV; Degtyareva AO; Korbolina EE; Damarov IS; Merkulova TI
Vavilovskii Zhurnal Genet Selektsii; 2023 Oct; 27(6):662-675. PubMed ID: 37965371
[TBL] [Abstract][Full Text] [Related]
19. Mapping of numerous disease-associated expression polymorphisms in primary peripheral blood CD4+ lymphocytes.
Murphy A; Chu JH; Xu M; Carey VJ; Lazarus R; Liu A; Szefler SJ; Strunk R; Demuth K; Castro M; Hansel NN; Diette GB; Vonakis BM; Adkinson NF; Klanderman BJ; Senter-Sylvia J; Ziniti J; Lange C; Pastinen T; Raby BA
Hum Mol Genet; 2010 Dec; 19(23):4745-57. PubMed ID: 20833654
[TBL] [Abstract][Full Text] [Related]
20. CTLA4 promoter polymorphisms are associated with canine diabetes mellitus.
Short AD; Saleh NM; Catchpole B; Kennedy LJ; Barnes A; Jones CA; Fretwell N; Ollier WE
Tissue Antigens; 2010 Mar; 75(3):242-52. PubMed ID: 20196832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
